Market Overview

Biotechnology - The Global Market to 2026 by Technology, Application and Geography -


The "Biotechnology
- Global Market Outlook (2017-2026)"
report has been added to's

Factors such as growing demand for agro-based products, reducing cost of
DNA sequencing, rising prevalence of chronic disorder are driving the
market growth. However, ethical issues associated with clinical trials
and risks associated with GM organisms and crops are restraining the
market growth.

By technology, the nanobiotechnology is expected to dominate the market.
Various drug delivery therapies use nanobiotechnology for chronic
disorders such as cancer. It involves the advancement of nanoparticle
based gold nanoparticles, chemotherapeutic drugs, and quantum dots for
molecular diagnosis and nanobiosensors which help in drug delivery and
optical imaging.

North America accounted for largest market share attributed to the
increase in investments in R&D pertaining to new drug discovery.

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porter's Five Forces Analysis

5 Global Biotechnology Market, By Technology

6 Global Biotechnology Market, By Application

7 Global Biotechnology Market, By Geography

8 Key Developments

9 Company Profiling

  • Gilead
  • Biogen
  • Celgene Corporation
  • AstraZeneca
  • Abbott Laboratories
  • Novo Nordisk A/S
  • Novartis AG
  • Lonza
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services Inc.
  • Pfizer Inc.
  • Sanofi Aventis
  • Merck & Co
  • Roche
  • Genentech

For more information about this report visit

View Comments and Join the Discussion!